Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients

Table 4 Plasma concentrations (μmol/L) of ADMA, SDMA, and arginine

	Just before TIPS		Directly after TIPS		3 mo after TIPS
	Median	IQR	Median	IQR	Median	IQR
ADMA
Caval vein	0.64	0.58-0.72	0.69	0.61-0.78	0.59	0.53-0.74
Portal vein	0.67	0.60-0.79	0.7	0.62-0.80	0.58	0.52-0.77
Hepatic vein	0.62	0.59-0.71	0.66	0.57-0.84	0.57	0.52-0.74
SDMA
Caval vein	0.74	0.60-1.16	0.81	0.64-1.11	0.61a	0.46-0.86
Portal vein	0.79	0.62-1.13	0.72	0.64-1.06	0.62a	0.46-0.89
Hepatic vein	0.79	0.61-1.09	0.77	0.64-1.09	0.60a	0.44-0.89
Arginine
Caval vein	64	56-85	76	68-102	77a	65-104
Portal vein	69	62-93	79	64-102	90a	70-106
Hepatic vein	54	46-75	67	59-88	72a	57-101
Arginine/ADMA
Caval vein	95	83-132	117	89-141	128a	110-175
Portal vein	83	68-123	98	80-130	123a	92-152
Hepatic vein	108	88-138	114	88-137	141a	112-185

^aP < 0.05 vs just before TIPS-placement.